SEC EDGAR CompanyFacts fact · reporting period
ONYX PHARMACEUTICALS INC: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$362.165M{"amount": 362165000, "concept": "us-gaap:Revenues", "currency": "USD"}- Entity
- ONYX PHARMACEUTICALS INC
- Metric
- revenue
- Period
- 2012-01-01 – 2012-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-09-01T13:09:45.506542+02:00
Raw response SHA-256
1b96cbbb151c8ba6505cdb3d203c8c3d…Official-identifier path
https://factanker.com/fact/sec/cik-0001012140/revenue/2012-12-31 (CIK, metric, reporting date)History
- supersedes {"amount": 63955000, "concept": "us-gaap:SalesRevenueGoodsNet", "currency": "USD"} (evidence 0001047469-13-001966)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.